To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbBiocon Ltd Share Price
breadcrumbResults

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on June 30, 2025Data in Crores of INR
Revenue
₹ 3.94K+14.83% from last year
Operating profits
₹ 828.60-52.78% from last year
Net income
₹ 89.20-89.65% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002
Net worth21644.0019783.7017866.908432.507626.906705.806098.005180.804837.704033.803270.603026.702694.602272.402032.801757.851510.741484.151068.61888.10740.52562.93134.1887.53
Fixed assets31963.3030643.6029467.706569.006363.905971.104471.003699.503625.101748.301629.901525.201510.301270.501316.201337.931211.56931.28894.90300.99253.67160.74135.91112.67
Debt17755.5015729.6017770.704904.004358.602625.402407.002264.002302.502477.701117.20863.70267.30270.80334.10513.61523.92255.06186.77105.0576.3464.6968.5766.75
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010FY2009FY2008FY2007FY2006FY2005FY2004
Operating4061.202953.901852.501176.601159.701283.101154.60662.10640.00370.60210.70560.70471.20564.10798.50443.8195.10317.91154.7680.94172.43128.65
Investing -234.10-1004.50-14281.80-1699.10-3624.70-1558.90-713.80-684.00-498.50-1141.70-508.70-938.10-375.80-359.50-314.50-226.07-232.19-340.15-191.17-88.82-485.21-108.08
Financing -1854.00-2332.7013048.70242.102564.00387.60-241.70-239.70-177.501067.60186.20426.00-8.60-186.30-274.60-85.21136.9323.2243.094.67-1.76294.31

Financial ratios

Profitability ratiosinfo2
ROA2.5%
ROE7.03%
ROCE7.43%
EPS8.44%
Net profit margin9.37%
Operating profit margin28.52%
Dividend per share0.5%
Operational ratiosinfo2
Quick ratio0.79%
Current ratio1.14%
Interest coverage3.1%
Assets turnover0.27%
Debt to equity0.84%
Valuation ratiosinfo2
P/E ratio124.79%
P/B ratio1.86%
Dividend yield0.14%
EV/EBITDA
Biocon Limited is engaged in the manufacture of biotechnology products and research services. It is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.
personal

Grow your wealth with more research recommendations

+91